Olendalizumab, CAS 2210314-30-8

Product Description: Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Dysinger M, et al. A Gyrolab Assay for the Quantitation of Free Complement Protein C5a in Human Plasma. AAPS J. 2018 Oct 2;20(6):106. /[2]Annane D, et al. Methods for treating a complement mediated disorder caused by viruses. World Intellectual Property Organization, WO2021211940 A1. 2021-10-21.

CAS Number: 2210314-30-8

Molecular Weight: N/A

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Complement System

• Artikelnummer: MEXHY-P99767-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99767-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated